XML 96 R80.htm IDEA: XBRL DOCUMENT v3.3.1.900
Stockholders' Equity (Employee and Director Stock Options, Restricted Stock and ESPP) (Details 2) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Jan. 02, 2016
Jan. 03, 2015
Dec. 28, 2013
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Total unrecognized compensation cost related to unvested employee and director stock options $ 10,800    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Beginning balance 9,369,000    
Grants as a result of Acquisition 2,087,000    
Granted 2,348,000    
Exercised (1,159,000)    
Forfeited or expired (1,201,000)    
Ending balance 11,444,000 9,369,000  
Vested and expected to vest at end of period, Shares 11,444,000    
Exercisable at end of period, Shares 6,692,000    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]      
Beginning balance $ 5.45    
Grants as a result of Acquisition 4.63    
Granted 5.68    
Exercised 3.95    
Forfeited or expired 5.77    
Ending balance 5.46 $ 5.45  
Vested and expected to vest at end of period, Weighted average exercise price 5.46    
Exercisable at end of period, Weighted average exercise price $ 5.32    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]      
Vested and expected to vest at end of period, Weighted average remaining contractual term 4 years 3 months 4 days    
Vested and expected to vest at end of period, aggregate intrinsic value $ 12,719    
Exercisable at end of period, Weighted average remaining contractual term 3 years 3 months 4 days    
Exercisable at end of period, aggregate intrinsic value $ 8,256    
Total intrinsic value of options exercised 2,500 $ 7,800 $ 2,500
Total fair value of options and RSU's vested and expensed $ 18,000 $ 12,800 $ 9,300
Grant date weighted average fair values based on fair value assumptions, options $ 2.35 $ 2.93 $ 2.10
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Grants as a result of Acquisition 2,087,000    
Compensation expense $ 21,643 $ 12,802 $ 9,522
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]      
Grants as a result of Acquisition $ 4.63    
Stock options      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Expected volatility, percent, minimum 43.60% 45.40% 51.40%
Expected volatility, percent, maximum 47.30% 50.40% 543.00%
Risk-free interest rate, percent, minimum 1.40% 1.50% 0.70%
Risk-free interest rate, percent, maximum 1.70% 1.70% 1.00%
Dividend yield 0.00% 0.00% 0.00%
Weighted average period for recognition 4 years 2 months    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Ending balance 1,622,007    
Stock options | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Expected term (years) 4 years 29 days 4 years 1 month 6 days 4 years 1 month 6 days
Stock options | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Expected term (years) 4 years 9 months 4 years 8 months 12 days 4 years 6 months
ESPP      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Expected term (years) 6 months 6 months 6 months
Dividend yield 0.00% 0.00% 0.00%
Weighted average expected volatility rate (percent) 33.60% 38.70% 48.00%
Risk-free interest rate 0.12% 0.08% 0.11%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]      
Grant date weighted average fair values based on fair assumptions, non-options $ 1.51 $ 1.73 $ 1.29
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]      
Granted, Weighted average grant date fair value $ 1.51 $ 1.73 $ 1.29
Restricted Stock Units (RSUs)      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Expected term (years) 2 years 2 months 27 days  
Dividend yield 0.00% 0.00%  
Risk-free interest rate 0.60% 2.20%  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Grants as a result of Acquisition 2,025,000    
Granted 70,000 98,600 0
Ending balance 1,056,368    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]      
Grants as a result of Acquisition $ 5.37    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]      
Grant date weighted average fair values based on fair assumptions, non-options $ 5.92    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Balance at the beginning of period, Shares 2,021,000    
Grants as a result of Acquisition 2,025,000    
Granted, Shares 3,203,000    
Vested, Shares (1,624,000)    
Compensation expense   $ 700  
Forfeited, Shares (868,000)    
Balance at the end of period, Shares 4,757,000 2,021,000  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]      
Balance at the beginning of period, Weighted average grant date fair value $ 6.66    
Grants as a result of Acquisition 5.37    
Granted, Weighted average grant date fair value 5.92    
Vested, Weighted average grant date fair value 6.04    
Forfeited, Weighted average grant date fair value 6.02    
Balance at the end of period, Weighted average grant date fair value $ 5.95 $ 6.66  
Unrecognized compensation expense related to unvested RSU's $ 24,400